SCHEMBL9920751

SCHEMBL9920751

c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4ccc5c(-c6cccc(-n7c8ccccc8c8ccccc87)c6)ccc6ccc3c4c65)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
ATM Q13315 2/20 0.44
KDM4E B2RXH2 1/20 0.44
PDE10A Q9Y233 1/20 0.34
CYP1A2 P05177 2/20 0.33
ERBB2 P04626 1/20 0.33
FYN P06241 1/20 0.33
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33
AHR P35869 1/20 0.33
MAPK14 Q16539 1/20 0.33
KMT2A Q03164 4/20 0.33
IL1R1 P14778 1/20 0.33
ALDH1A1 P00352 4/20 0.32
MEN1 O00255 3/20 0.32
HTT P42858 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HSD17B10 Q99714 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9920727 0.93 L3MBTL1 (0.45) L3MBTL1ATMKDM4EPDE10ACYP1A2
SCHEMBL9920754 0.93 L3MBTL1 (0.47) L3MBTL1ATMKDM4EPDE10ACYP1A2
SCHEMBL12611554 0.93 L3MBTL1 (0.47) L3MBTL1ATMKDM4EPDE10ACYP1A2
SCHEMBL9921054 0.92 L3MBTL1 (0.42) L3MBTL1ATMKDM4EPDE10ACYP1A2
SCHEMBL9920943 0.91 L3MBTL1 (0.41) L3MBTL1ATMKDM4EPDE10ACYP1A2
SCHEMBL9921066 0.91 L3MBTL1 (0.43) L3MBTL1ATMKDM4EPDE10ACYP1A2
SCHEMBL9920964 0.90 L3MBTL1 (0.44) L3MBTL1ATMKDM4EPDE10ACYP1A2
SCHEMBL9920790 0.90 L3MBTL1 (0.44) L3MBTL1ATMKDM4EPDE10ACYP1A2
SCHEMBL9921065 0.89 L3MBTL1 (0.42) L3MBTL1ATMKDM4EPDE10ACYP1A2
SCHEMBL9939617 0.89 L3MBTL1 (0.42) L3MBTL1ATMKDM4EPDE10ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463352-B1 Light emitting device material and light emitting device TORAY INDUSTRIES (JP) 2018-05-02 EP disclosed
EP-1942171-B1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES (JP) 2018-04-18 EP disclosed
EP-2463352-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
EP-2463351-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
EP-1942171-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2008-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090096356-A1 Light-emitting device material and light-emitting device PRMT9, CCNL2, MRPL9 L3MBTL1 283/4885ATM 1983/4885KDM4E 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.